The downgrade from Outperform to Neutral by a prominent analyst, along with a significant reduction in the price target, suggests a more cautious or bearish outlook on Healthcare Realty Trust's stock. This could lead to short-term negative sentiment among investors, potentially impacting the stock's price negatively.